Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Looks good AH,..
dayend: 3.13
+0.10 (+3.30%)
After Hours: 3.47 +0.34 (+10.86%)
Jul 12, 5:15PM EDT
Small cap biotech stock ADVENTRX Pharmaceuticals, Inc. (AMEX:ANX) is no stranger to us. This chart's been much-watched for months now.... mostly because of its implosion. The tide may well be turning though.
While it's yet to crawl above it, ANX shares have made a persistent attack on the 20-day line over the last month and a half. In fact, I'd say the stock's pushing it upward now, even though it's yet to break it. If ADVENTRX Pharmaceuticals can just crack the 50-day line at $2.03, I'd consider it a strong technical (short term) buy.
http://www.smallcapnetwork.com/Oh-So-Close-Outlooks-for-KG-ANX-and-GAME/s/article/view/p/mid/3/id/357/
at this pps this is an realistic take-over candidate in my opinion.. also with a 100% premium..
I also believe big investors will soon buy this stock.. at this low point..
I expect an huge up potential here, just 23 milion marked cap at this pps..
You have to be on time.. to buy low, and sell hi, this time is now imo..
June 30, 2010 (FinancialWire) (Go to http://www.financialwire.net/?s=ftrdnwswnd for all of today's featured news.) -- Adventrx Pharmaceuticals, Inc. (AMEX: ANX | PowerRating) was added to the Russell Microcap Index on June 25, when Russell Investments
reconstituted its line of U.S. indexes. The Russell Microcap Index measures the performance of the microcap segment of the U.S. equity market. It includes 1,000 of the smallest securities in the small-cap Russell 2000 Index based on a combination of their market cap and current index membership and it includes the next 1,000 securities.
Russell's indexes are used by investment managers and institutional investors for index funds and as benchmarks for passive and active investment strategies. They are reconstituted annually.
whats this worth now.. I think soon under 0.10
bilion dollars lost.. !! (incl freddie)
Strange US administration to let all this money flow away..
A stock split and save this gouvermentstock would be beter for all.. Now its almost over.. There is only one door out..
We get a rally...
the step-outs are out, now it will rally up.. imo
News this week, brings this in the $6,-
Looks like a buyer is buying all on its way..
Never seen this whitout news.. hope its big..
+30% whats going on.. looks like news is pending..
Yes you are right.. afher the big buy dated fillings 25-6-2010. this was a payment in for 4 members total about 8.500 ps. (not that mutch)
grtz.. leon
if manegment is buying stocks at this low, I think they are done or didnt dilute, or will not dilute in near future..
nexm board is buying stocks..
http://ih.advfn.com/p.php?pid=squote&symbol=nexmd
Date Time Headline More NEXMD News
07/02/2010 1:27PM Statement of Changes in Beneficial Ownership (4)
07/02/2010 1:25PM Statement of Changes in Beneficial Ownership (4)
07/02/2010 1:24PM Statement of Changes in Beneficial Ownership (4)
07/02/2010 1:21PM Statement of Changes in Beneficial Ownership (4)
Thats always good te see/know..
company dilutes this down..
shorts take a big risk here, its now on its all time low.. big news ahead..
hope we fly over 2 dollar today..
could go hard up, the comming months.. we are almost in 3 th quarter.. tomorow..
and the 9 months data is already on the screen..
If you ask me "the jail door" could be open for this CEO.. looks like this merger was fake only to dump... This needs an SEC investigation if you ask me.. This was also my opinion when I posted the merger news here on this board..
Its not posible that is isnt posible to write an PR.. sinds feb. almost 4 months ago.. and let investors pay his salary and bonus to all the printed shares he sold..
gilty in the first digree..
totday last day of june.. ??? lets see if he has something for this last day of this quarter..
On every sell a new steps in. You get 5 times more shares than 8 weeks ago.. for the same money.. I would buy more if this goes down more.. a run up can go hard.. we`ll see what happens.. I still hope company gives us an nice update of other PR news-item..
Its always posible ANX could be take-over target at these all time low pps and marketcap..
I did today... there has to be a turning point.. UP
after spit company dilute a few milion.. even knowing that, this should be over $4 at least.. I wonder who is selling now, at this long ride down.. Its time this should give news, and a big rally up..
more than 80% down.. sinds the split.. 26 april..
gltya
its about time for a big rally here..
An merger PR would be nice to see this week..
electric car company`s have to menger, to get bigger, for bigger output and lower costs.. (save oil)..
this is a future goldmine for investors.. a good time to jump in so I did..
gltya...
I agree.. bought a big stake..
succes to all..
I am up for a nice run today.. lets do it.. lol
could be 2 things..
-short contracts bought..
-MM try to hold a big fall, and sold down later.
I expected more vollume down..
Company did dilute first.. !! ??
24/5
The number of shares of common stock entitled to vote at the annual meeting was 126,902,281.
http://ih.advfn.com/p.php?pid=nmona&article=43003947&symbol=N%5ENEXM
17/6
the total number of authorized shares of common stock of the Company will be decreased from 270,000,000 shares (marked-cap $+80 mil.) of common stock to 18,000,000 shares of common stock
http://ih.advfn.com/p.php?pid=nmona&article=43278780&symbol=N%5ENEXM
a split is killing this.. it was 6 weeks ago also on ANX @0.27 (25 for 1 new) so it was $6.75 see now it fall to $1.83 lost more than almost 80% in 6 weeks.. pff
I was expecting this on nexm to, like more people here, lucky got out on 0.325 the risk to hold overnight was hi, often they do it when they put out a PR the day before.. (then I got out) pff
"NexMed Releases Pre-Clinical Results on Its Proprietary Calcipotriene Betamet...
Trading Markets - Jun 15, 2010"
It should be criminal to put out this kind of split-PR.. it makes financial victims.. CEO in jail if you ask me..
big buy Afther Hours..
18:16 - $ 0.5562 - 667,802
?????
If you realy think this is going up., then why not buy FRE that one went down more than FNM ?
FRE lost $0.70
FNM lost $0.48
(last 2 days)
I think big investors will step out.. they simply not trade stocks in Otcbb.. there are more than 700 mil. not trayded stocks.. imo so I think wait a few days in low 30 to take a risk to buy in.. MM try to stop the big down now..
75% O/S is not trayded yesterday.. what will they do.. ?
It will go down hard again today.... imo
I think around 0.65 is posible..
imo this is an take-over company in a few months..
also from me..
where are valley and p2d now ?? and why are they not posting here anymore.. ?
good news out, its posible a big company does a take-over bid.. with this millstone paymend this company is more undervaliued than it was before.. imo
ADVENTRX Grants Exclusive Worldwide Rights to CoFactor Know-How and Data
SAN DIEGO, June 10 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) announced today that it has granted Theragence, Inc. exclusive, worldwide rights under its know-how to develop, make, use and sell 5,10-methylenetetrahydrofolate, also known as ANX-510 or CoFactor. Under the terms of their agreement, Theragence will use commercially reasonably efforts to research, develop and commercialize licensed products. ADVENTRX will receive royalties on net sales of licensed products and up to approximately $30 million in commercial milestones based on aggregate gross sales of licensed products in the United States, European Union and Japan.
"While our focus remains on ANX-530, or Exelbineâ„¢, and ANX-514, we constantly seek to create value from all of our assets, including through strategic alliances for those product candidates that may be outside our core business," stated Brian M. Culley, Chief Executive Officer of ADVENTRX. "Theragence's computational approach to analyzing data may provide valuable insight into specific populations for which CoFactor can improve clinical outcomes."
In October 2007, ADVENTRX reported the results of a Phase 2b study in which CoFactor, in combination with 5-fluorouracil, did not demonstrate statistically significant improved safety in the trial's primary endpoint. In November 2007, ADVENTRX discontinued enrolling patients in its Phase 3 clinical trial of CoFactor for the treatment of metastatic colorectal cancer and, in October 2008, ADVENTRX discontinued active work on its CoFactor program.